Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer

Jennifer J. Ascão, Henry Frierson, Christopher A. Moskaluk, Jeffrey C. Harper, Franco Roviello, Charles E. Jackson, Wael El-Rifai, Carla Vindigni, Piero Tosi, Steven M. Powell

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Loss of the cell adhesion molecule E-cadherin has been observed in a variety of human carcinomas, and germline E-cadherin mutations have been found in several familial cases of diffuse gastric cancer. We sought to determine the prevalence and nature of E-cadherin alterations in "sporadic" gastric carcinomas. We performed comprehensive sequencing of the coding region, loss of heterozygosity (LOH) analysis, and immunohistochemical protein expression determination on 40 sporadic gastric adenocarcinomas. In total, 7 of 25 diffuse-type cancers harbored genetic alterations in the E-cadherin gene. Novel mutations predicted to significantly compromise protein function were found within 4 of these cancers, 2 of which harbored alterations resulting in biallelic inactivation of the gene product. Three diffuse cancers failed to amplify Exon 8 of E-cadherin, suggesting the presence of a homozygous abnormality. Notably, one germline E-cadherin mutation was also identified within these "sporadic" diffuse cancers. Significant gene mutations were not found in the 14 intestinal-type or histologically mixed cancer. Immunohistochemistry revealed aberrant or negative protein expression in seven diffuse-type tumors, four of which correlated with the genetic alterations. Both diffuse and intestinal-type tumors exhibited low rates of LOH, suggesting that allelic loss at the locus is not a common mechanism for E-cadherin inactivation during gastric tumorigenesis. Our observations suggest that inactivation of the E-cadherin gene occurs only in a subset of diffuse-type gastric cancers, as the majority of cases did not contain genetic alterations or identifiable protein abnormalities. Germline E-cadherin alterations, although rare, may underlie some diffuse gastric cancer cases that have important biologic and practical implications.

Original languageEnglish (US)
Pages (from-to)942-949
Number of pages8
JournalModern Pathology
Volume14
Issue number10
DOIs
StatePublished - Oct 29 2001
Externally publishedYes

Fingerprint

Cadherins
Stomach Neoplasms
Genes
Loss of Heterozygosity
Neoplasms
Stomach
Mutation
Proteins
Carcinoma
Cell Adhesion Molecules
Gene Silencing
Exons
Carcinogenesis
Adenocarcinoma
Immunohistochemistry

Keywords

  • Diffuse-type gastric cancer
  • E-cadherin
  • LOH
  • Sporadic gastric cancer

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Ascão, J. J., Frierson, H., Moskaluk, C. A., Harper, J. C., Roviello, F., Jackson, C. E., ... Powell, S. M. (2001). Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Modern Pathology, 14(10), 942-949. https://doi.org/10.1038/modpathol.3880416

Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. / Ascão, Jennifer J.; Frierson, Henry; Moskaluk, Christopher A.; Harper, Jeffrey C.; Roviello, Franco; Jackson, Charles E.; El-Rifai, Wael; Vindigni, Carla; Tosi, Piero; Powell, Steven M.

In: Modern Pathology, Vol. 14, No. 10, 29.10.2001, p. 942-949.

Research output: Contribution to journalArticle

Ascão, JJ, Frierson, H, Moskaluk, CA, Harper, JC, Roviello, F, Jackson, CE, El-Rifai, W, Vindigni, C, Tosi, P & Powell, SM 2001, 'Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer', Modern Pathology, vol. 14, no. 10, pp. 942-949. https://doi.org/10.1038/modpathol.3880416
Ascão JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Modern Pathology. 2001 Oct 29;14(10):942-949. https://doi.org/10.1038/modpathol.3880416
Ascão, Jennifer J. ; Frierson, Henry ; Moskaluk, Christopher A. ; Harper, Jeffrey C. ; Roviello, Franco ; Jackson, Charles E. ; El-Rifai, Wael ; Vindigni, Carla ; Tosi, Piero ; Powell, Steven M. / Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. In: Modern Pathology. 2001 ; Vol. 14, No. 10. pp. 942-949.
@article{78d6c010fc274709a560e11a8a4b2a66,
title = "Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer",
abstract = "Loss of the cell adhesion molecule E-cadherin has been observed in a variety of human carcinomas, and germline E-cadherin mutations have been found in several familial cases of diffuse gastric cancer. We sought to determine the prevalence and nature of E-cadherin alterations in {"}sporadic{"} gastric carcinomas. We performed comprehensive sequencing of the coding region, loss of heterozygosity (LOH) analysis, and immunohistochemical protein expression determination on 40 sporadic gastric adenocarcinomas. In total, 7 of 25 diffuse-type cancers harbored genetic alterations in the E-cadherin gene. Novel mutations predicted to significantly compromise protein function were found within 4 of these cancers, 2 of which harbored alterations resulting in biallelic inactivation of the gene product. Three diffuse cancers failed to amplify Exon 8 of E-cadherin, suggesting the presence of a homozygous abnormality. Notably, one germline E-cadherin mutation was also identified within these {"}sporadic{"} diffuse cancers. Significant gene mutations were not found in the 14 intestinal-type or histologically mixed cancer. Immunohistochemistry revealed aberrant or negative protein expression in seven diffuse-type tumors, four of which correlated with the genetic alterations. Both diffuse and intestinal-type tumors exhibited low rates of LOH, suggesting that allelic loss at the locus is not a common mechanism for E-cadherin inactivation during gastric tumorigenesis. Our observations suggest that inactivation of the E-cadherin gene occurs only in a subset of diffuse-type gastric cancers, as the majority of cases did not contain genetic alterations or identifiable protein abnormalities. Germline E-cadherin alterations, although rare, may underlie some diffuse gastric cancer cases that have important biologic and practical implications.",
keywords = "Diffuse-type gastric cancer, E-cadherin, LOH, Sporadic gastric cancer",
author = "Asc{\~a}o, {Jennifer J.} and Henry Frierson and Moskaluk, {Christopher A.} and Harper, {Jeffrey C.} and Franco Roviello and Jackson, {Charles E.} and Wael El-Rifai and Carla Vindigni and Piero Tosi and Powell, {Steven M.}",
year = "2001",
month = "10",
day = "29",
doi = "10.1038/modpathol.3880416",
language = "English (US)",
volume = "14",
pages = "942--949",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer

AU - Ascão, Jennifer J.

AU - Frierson, Henry

AU - Moskaluk, Christopher A.

AU - Harper, Jeffrey C.

AU - Roviello, Franco

AU - Jackson, Charles E.

AU - El-Rifai, Wael

AU - Vindigni, Carla

AU - Tosi, Piero

AU - Powell, Steven M.

PY - 2001/10/29

Y1 - 2001/10/29

N2 - Loss of the cell adhesion molecule E-cadherin has been observed in a variety of human carcinomas, and germline E-cadherin mutations have been found in several familial cases of diffuse gastric cancer. We sought to determine the prevalence and nature of E-cadherin alterations in "sporadic" gastric carcinomas. We performed comprehensive sequencing of the coding region, loss of heterozygosity (LOH) analysis, and immunohistochemical protein expression determination on 40 sporadic gastric adenocarcinomas. In total, 7 of 25 diffuse-type cancers harbored genetic alterations in the E-cadherin gene. Novel mutations predicted to significantly compromise protein function were found within 4 of these cancers, 2 of which harbored alterations resulting in biallelic inactivation of the gene product. Three diffuse cancers failed to amplify Exon 8 of E-cadherin, suggesting the presence of a homozygous abnormality. Notably, one germline E-cadherin mutation was also identified within these "sporadic" diffuse cancers. Significant gene mutations were not found in the 14 intestinal-type or histologically mixed cancer. Immunohistochemistry revealed aberrant or negative protein expression in seven diffuse-type tumors, four of which correlated with the genetic alterations. Both diffuse and intestinal-type tumors exhibited low rates of LOH, suggesting that allelic loss at the locus is not a common mechanism for E-cadherin inactivation during gastric tumorigenesis. Our observations suggest that inactivation of the E-cadherin gene occurs only in a subset of diffuse-type gastric cancers, as the majority of cases did not contain genetic alterations or identifiable protein abnormalities. Germline E-cadherin alterations, although rare, may underlie some diffuse gastric cancer cases that have important biologic and practical implications.

AB - Loss of the cell adhesion molecule E-cadherin has been observed in a variety of human carcinomas, and germline E-cadherin mutations have been found in several familial cases of diffuse gastric cancer. We sought to determine the prevalence and nature of E-cadherin alterations in "sporadic" gastric carcinomas. We performed comprehensive sequencing of the coding region, loss of heterozygosity (LOH) analysis, and immunohistochemical protein expression determination on 40 sporadic gastric adenocarcinomas. In total, 7 of 25 diffuse-type cancers harbored genetic alterations in the E-cadherin gene. Novel mutations predicted to significantly compromise protein function were found within 4 of these cancers, 2 of which harbored alterations resulting in biallelic inactivation of the gene product. Three diffuse cancers failed to amplify Exon 8 of E-cadherin, suggesting the presence of a homozygous abnormality. Notably, one germline E-cadherin mutation was also identified within these "sporadic" diffuse cancers. Significant gene mutations were not found in the 14 intestinal-type or histologically mixed cancer. Immunohistochemistry revealed aberrant or negative protein expression in seven diffuse-type tumors, four of which correlated with the genetic alterations. Both diffuse and intestinal-type tumors exhibited low rates of LOH, suggesting that allelic loss at the locus is not a common mechanism for E-cadherin inactivation during gastric tumorigenesis. Our observations suggest that inactivation of the E-cadherin gene occurs only in a subset of diffuse-type gastric cancers, as the majority of cases did not contain genetic alterations or identifiable protein abnormalities. Germline E-cadherin alterations, although rare, may underlie some diffuse gastric cancer cases that have important biologic and practical implications.

KW - Diffuse-type gastric cancer

KW - E-cadherin

KW - LOH

KW - Sporadic gastric cancer

UR - http://www.scopus.com/inward/record.url?scp=17944375244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944375244&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3880416

DO - 10.1038/modpathol.3880416

M3 - Article

VL - 14

SP - 942

EP - 949

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 10

ER -